136 related articles for article (PubMed ID: 38028146)
1. Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort.
Aboelhassan R; Sobeih ME; El-Din MA; Ghali RR; El-Din IS; Khorshid O; Mokhtar M; Rabea AM; Belal A; Azim HA; Abdullah M; Elnahas T; Tawfik H; Abdelwahab S; Elsaid AA; Hashem T; Mancy M; Farag H
Ther Adv Med Oncol; 2023; 15():17588359231212182. PubMed ID: 38028146
[TBL] [Abstract][Full Text] [Related]
2. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
Prabhash K; Tan DSW; Soo RA; Sitthideatphaiboon P; Chen YM; Voon PJ; Syahruddin E; Chu S; Huggenberger R; Cho BC
Front Oncol; 2023; 13():1117348. PubMed ID: 37051534
[TBL] [Abstract][Full Text] [Related]
3. Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa - KINDLE Study.
Jazieh AR; Sağlam EK; Önal HC; Abdelkader Y; Gaafar R; Dawoud E; Nassar M; Alshorbagy D; El Ashry H; Elsayed M
Clin Lung Cancer; 2022 Jun; 23(4):364-373. PubMed ID: 35277345
[TBL] [Abstract][Full Text] [Related]
4. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study.
Jazieh AR; Onal HC; Tan DSW; Soo RA; Prabhash K; Kumar A; Huggenberger R; Robb S; Cho BC
J Thorac Oncol; 2021 Oct; 16(10):1733-1744. PubMed ID: 34051381
[TBL] [Abstract][Full Text] [Related]
5. Real-world KINDLE-Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non-small-cell lung cancer.
Martin CM; Puello-Guerrero A; Mas-Lopez LA; Campos-Gómez S; Orlando-Orlandi FJ; Tejado Gallegos LF; Huggenberger R
Cancer Med; 2023 Jan; 12(2):1247-1259. PubMed ID: 35789068
[TBL] [Abstract][Full Text] [Related]
6. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort.
Van Dao T; Diep TB; Le Phuong T; Huggenberger R; Kumar A
Front Oncol; 2022; 12():842296. PubMed ID: 35677172
[TBL] [Abstract][Full Text] [Related]
7. Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
Lee J; Ahn HK; Kim SW; Han JY; Lee SS; Park HS; Lee HW; Kim JH; Cho E; Huggenberger R; Cho BC
Cancer Med; 2024 Apr; 13(7):e7174. PubMed ID: 38622869
[TBL] [Abstract][Full Text] [Related]
8. Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study.
Jazieh AR; Onal HC; Tan DS; Soo RA; Prabhash K; Kumar A; Huggenberger R; Cho BC
Ther Adv Med Oncol; 2022; 14():17588359221122720. PubMed ID: 36119641
[TBL] [Abstract][Full Text] [Related]
9. An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study.
Su PL; Chang GC; Hsiao SH; Hsia TC; Lin MC; Lin MH; Shih JY; Yang CT; Yang SH; Chen YM
JTO Clin Res Rep; 2022 Mar; 3(3):100292. PubMed ID: 35252898
[TBL] [Abstract][Full Text] [Related]
10. Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.
Agulnik J; Kasymjanova G; Pepe C; Hurry M; Walton RN; Sakr L; Cohen V; Lecavalier M; Small D
Curr Oncol; 2020 Oct; 27(5):e459-e466. PubMed ID: 33173385
[TBL] [Abstract][Full Text] [Related]
11. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
12. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
[TBL] [Abstract][Full Text] [Related]
13. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study.
Horinouchi H; Atagi S; Oizumi S; Ohashi K; Kato T; Kozuki T; Seike M; Sone T; Sobue T; Tokito T; Harada H; Maeda T; Mio T; Shirosaka I; Hattori K; Shin E; Murakami H
Cancer Med; 2020 Sep; 9(18):6597-6608. PubMed ID: 32730697
[TBL] [Abstract][Full Text] [Related]
14. Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.
Konert T; Vogel WV; Paez D; Polo A; Fidarova E; Carvalho H; Duarte PS; Zuliani AC; Santos AO; Altuhhova D; Karusoo L; Kapoor R; Sood A; Khader J; Al-Ibraheem A; Numair Y; Abubaker S; Soydal C; Kütük T; Le TA; Canh NX; Bieu BQ; Ha LN; Belderbos JSA; MacManus MP; Thorwarth D; Hanna GG
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2235-2243. PubMed ID: 31367906
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION study.
Murakami H; Horinouchi H; Harada H; Sobue T; Kato T; Atagi S; Kozuki T; Tokito T; Oizumi S; Seike M; Ohashi K; Mio T; Sone T; Jinushi M; Tsuboi M
Lung Cancer; 2022 Mar; 165():152-163. PubMed ID: 35144145
[TBL] [Abstract][Full Text] [Related]
16. Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Provencio M; Carcereny E; López Castro R; Calvo V; Rodríguez Abreu D; Cobo M; Ortega AL; Bernabé R; Guirado M; Massutí B; Del Barco-Morillo E; Bosch-Barrera J; Camps C; Carroll R; Rault C; Chaib C; Penrod J; Vo L; Ralphs E; Daumont MJ
Transl Lung Cancer Res; 2023 Oct; 12(10):2113-2128. PubMed ID: 38025806
[TBL] [Abstract][Full Text] [Related]
17. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
[TBL] [Abstract][Full Text] [Related]
18. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis.
Joosten PJM; Dickhoff C; van der Noort V; Smeekens M; Numan RC; Klomp HM; van Diessen JNA; Belderbos JSA; Smit EF; Monkhorst K; Oosterhuis JWA; van den Heuvel MM; Dahele M; Hartemink KJ
Interact Cardiovasc Thorac Surg; 2022 Mar; 34(4):566-575. PubMed ID: 34734237
[TBL] [Abstract][Full Text] [Related]
19. [Value of surgery for stage IIIa non-small cell lung cancer].
Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
[TBL] [Abstract][Full Text] [Related]
20. Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial.
Senan S; Özgüroğlu M; Daniel D; Villegas A; Vicente D; Murakami S; Hui R; Faivre-Finn C; Paz-Ares L; Wu YL; Mann H; Dennis PA; Antonia SJ
ESMO Open; 2022 Apr; 7(2):100410. PubMed ID: 35247871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
